Statistics for Prevalence of CYP2D6 and CYP2C19 genotypes and metabolizer status in patients on neuropsychiatric therapy:
Total visits
| views | |
|---|---|
| Prevalence of CYP2D6 and CYP2C19 genotypes and metabolizer status in patients on neuropsychiatric therapy: | 106 |
Total visits per month
| views | |
|---|---|
| May 2025 | 5 |
| June 2025 | 3 |
| July 2025 | 4 |
| August 2025 | 7 |
| September 2025 | 4 |
| October 2025 | 0 |
| November 2025 | 1 |
File Visits
| views | |
|---|---|
| TM_Ana_Pereira.pdf | 90 |
| ulfl_tm.pdf | 2 |
| ULFBA_E_v8_iss17_p64-71.pdf | 1 |
Top country views
| views | |
|---|---|
| Portugal | 34 |
| United States | 16 |
| China | 14 |
| Brazil | 7 |
| Germany | 6 |
| Iran | 4 |
| Australia | 3 |
| Argentina | 2 |
| Japan | 2 |
| Peru | 2 |
| Belgium | 1 |
| Canada | 1 |
| Colombia | 1 |
| Costa Rica | 1 |
| Czechia | 1 |
| United Kingdom | 1 |
| Qatar | 1 |
| Romania | 1 |
| Saudi Arabia | 1 |
| Thailand | 1 |
Top city views
| views | |
|---|---|
| Lisbon | 1 |